Navigation Links
China Holdings Announces Starwood Research Institute Initiates Research Coverage
Date:2/15/2008

ture collaboration agreements, economic performance and trends, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward looking, all forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements, which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue," or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. The company has no obligation to update these forward-looking statements. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company's industry and general economy; government policies, competitive factors; ability to attract and retain personnel; the price of the Company's stock; and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. In a
'/>"/>
SOURCE China Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. China Display Technologies, Inc. to Present at Roth Conference
2. Renowned Chinese Herbal Medicine Development Specialist Joins China Health Resources
3. Wall Street Reporter Spotlights China Holdings Inc. and Asias Hunger for Alternative Energy
4. Chinas Environment, Health Examined in New Wilson Center Report
5. Red Cross Partners with YeePay on China Snow Disaster Relief
6. China Sky One Medical Raises $25 Million in Private Placement
7. DuPont Opens Fluoropolymer Production Plant in China
8. China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection
9. China Medical Technologies to Announce Financial Results for the Third Quarter Ended December 31, 2007 on February 28, 2008
10. China Nepstar Chain Drugstore Launches Charitable Initiative to Promote Awareness of Low-income Working Womens Health Issues
11. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Michigan Cosmetic Surgeon Debunks Top 3 Breast Implant Myths 2Health News:Halloween Events in Sacramento Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Central Valley, Calif. Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Central Valley, Calif. Bring Young and Old Together for a Ghoulish Good Time 3Health News:Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel 2Health News:Healthy planet, places and people at risk 2Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 2Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 3Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 4Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 5Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 6Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 7Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 8Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 9Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 10
Breaking Medicine Technology:RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3AHIP Statement on Passage of Senate Finance Committee Legislation 59409 1AHIP Statement on Passage of Senate Finance Committee Legislation 59409 2Americans United for Lifes Statement on Finance Committee Vote 59407 1New York Senators Chuck Schumer 28D NY 29 and Kirsten Gillibrand 28D NY 29 Join As Co Sponsors of The Lung Cancer Mortality Reduction Act 59405 1New York Senators Chuck Schumer 28D NY 29 and Kirsten Gillibrand 28D NY 29 Join As Co Sponsors of The Lung Cancer Mortality Reduction Act 59405 2New York Senators Chuck Schumer 28D NY 29 and Kirsten Gillibrand 28D NY 29 Join As Co Sponsors of The Lung Cancer Mortality Reduction Act 59405 3